FV-100
FV-100 is an investigational antiviral drug developed by Bristol-Myers Squibb for the treatment of herpes zoster, also known as shingles. It is a prodrug of CF-1743, which is a potent inhibitor of varicella zoster virus (VZV).
Mechanism of Action[edit | edit source]
FV-100 is a prodrug that is metabolized into its active form, CF-1743, in the body. CF-1743 inhibits the replication of VZV by interfering with the virus's DNA polymerase, an enzyme that is essential for the virus to multiply.
Clinical Trials[edit | edit source]
Several clinical trials have been conducted to evaluate the efficacy and safety of FV-100 in patients with herpes zoster. In a Phase II clinical trial, FV-100 was found to be more effective than valacyclovir, a commonly used antiviral drug, in reducing the severity and duration of shingles-associated pain.
Potential Advantages[edit | edit source]
FV-100 has several potential advantages over existing antiviral drugs for the treatment of herpes zoster. It is more potent against VZV, has a longer half-life, and may be associated with fewer side effects.
Potential Disadvantages[edit | edit source]
As an investigational drug, FV-100 is not yet approved for use in patients. Its safety and efficacy are still being evaluated in clinical trials.
See Also[edit | edit source]
FV-100 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD